Chemical Structure (Buprenorphine HCl Sublingual 1)
Buprenorphine Hydrochloride
Product Images NDC 53217-246
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 53217-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Buprenorphine HCl Sublingual 2)
Package Label (Buprenorphine HCl Sublingual 3)
This is a description of a medication called Buprenorphine HCI Sublingual. Each tablet contains 8 mg of the active ingredient Buprenorphine Hydrochloride, equivalent to Buprenorphine base. The tablet is round, white with & on one side and an MFG logo on the reverse. It is a generic for Subutex (NDC: 53217-0246-30) and should be taken every ___ hours ___ times a day. The medication is packaged by Thypha Pharma S.A. in France and the federal law prohibits dispensing without a prescription. Lot number, RX number, and INS number are also listed on the packaging.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
